Patents
Sitemap › C07 - Organic chemistry › C07J - Steroids › C07J 1 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, not substituted in position 17 beta by a carbon atom, e.g. oestrane, androstane
Patents for C07J 1 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, not substituted in position 17 beta by a carbon atom, e.g. oestrane, androstane (4,828)
12/2010
12/29/2010CN101445542B Process for preparing desogestrel
12/16/2010US20100317639 Medicament Based On a Monoester of Steroids With Long Chain Fatty Acids
12/16/2010US20100317628 MicroRNA Modulators and Method for Identifying and Using the Same
12/09/2010US20100311993 Process for preparing aromatiase inhibitor exemestane
12/08/2010CN101906128A Estrone compound, as well as preparation method and application thereof
12/07/2010US7846918 Exemestane compounds, compositions and related methods of use
12/07/2010US7846904 Compositions and methods for increasing telomerase activity
12/02/2010US20100305078 Metallo-oxidoreductase inhibitors using metal binding moieties in combination with targeting moieties
12/01/2010EP2256128A1 Method for synthesis of dienogest from estrone-3-methylether
12/01/2010CN1878786B Novel 17beta-hydroxysteroid dehydrogenase type I inhibitors
11/2010
11/30/2010US7842680 Diene and triene compounds and formulations
11/24/2010EP1910398B1 17-alpha-substituted derivatives of estradiol with wound-healing activity
11/24/2010CN101896186A Means and methods for counteracting muscle disorders
11/23/2010US7838516 for the estrogen receptor alpha-subtype; contraceptive; hot flushes, osteoporosis; 7 alpha-ethyl-15 beta-methyl-19-nor-17 alpha -pregna-1,3,5(10)-trien-20-yne-3,17 beta-diol
11/18/2010US20100291198 Compositions of phytosterols with enhanced bioavailability
11/17/2010EP2249838A1 Pharmaceutical solid state forms
11/11/2010US20100286105 Methods of treating hyperandrogenism and conditions associated therewith by administering a fatty acid ester of an estrogen or an estrogen derivative
11/10/2010CN1775946B Enhanced virus-mediated DNA transfer
10/2010
10/26/2010US7820642 Nandrolone 17β-carbonates
10/13/2010CN101857624A Preparation process of desogestrel and novel intermediate compound thereof
10/12/2010CA2457050C Prophylactic and therapeutic use of hydroxysteroids
10/06/2010CN101851262A Preparation method of 19-nor-4-androstenedione
09/2010
09/29/2010EP2231691A2 Process for preparing aromatase inhibitor exemestane
09/29/2010EP1771462B1 A process for the preparation of 7-alpha-alkylated 19-norsteroids
09/29/2010CN101845073A Preparation method and application of 1alpha-dehydroepiandrosterone
09/23/2010US20100240633 Cancer treatment methods
09/21/2010US7799770 For use in female birth control, for therapy of hormone-dependent gynecological disorders and for hormone replacement therapy
09/16/2010US20100233761 Algae biomass fractionation
09/15/2010CN101830937A Visualized double-reaction tube fluorine-18 multifunctional automated synthesis module
09/14/2010US7795299 11,15-dioxa-cyclopenta[a]phenanthren-12-one derivatives, used for the treatment of cancer; anticarcinogenic agents
09/14/2010US7795241 comprising 17-ethinylestradiol acetoxyacetate, used for hormone replacemnet therapy or as contraceptives; improved bioavailability
09/14/2010US7794802 Polymerizable liquid crystal compound, composition and polymer
09/07/2010US7790910 Process for the preparation of 7α-alkylated 19-norsteroids
09/02/2010WO2010096928A1 Digital microfluidic liquid-liquid extraction device and method of use thereof
09/02/2010US20100222571 Process for the preparation of drospirenone
09/02/2010US20100222313 Pharmaceutical compositions-4
09/02/2010US20100222286 Receptor modulators exhibiting neuroprotective and memory enhancing activities
09/02/2010US20100221213 Y-shape branched hydrophilic polymer derivatives, their preparation methods, conjugates of the derivatives and drug molecules, and pharmaceutical compositions comprising the conjugates
09/02/2010CA2753617A1 Digital microfluidic liquid-liquid extraction device and method of use thereof
08/2010
08/24/2010CA2458468C Use of non-feminizing estrogens as retinoprotective agents for the treatment of glaucoma
08/17/2010US7776845 Pharmaceutical compositions
08/12/2010US20100204497 Process For The Preparation of 7 alpha-Methylsteroids
08/12/2010US20100204492 process for the extraction of bioactive lignans with high yield and purity from sesame oil
08/11/2010EP2215104A1 11 -fluoro-3-acetoxyestra-3,5-diene-17-on and method for the production thereof
08/11/2010CN101182565B Extraction and purification method of 7 Alpha, 15Alpha-dihydroxy androstene alcohol ketone
08/10/2010US7772218 Synthesis of steroids, especially 3-hydroxy-7 alpha -methyl-21-[2'-methoxy-4'-(diethylaminomethyl)-phenoxy]-19-norpregna-1,3,5(10)triene citrate and treatment of prostate disorders such as prostatic cancer.
08/10/2010CA2463227C Steroidal compounds for inhibiting steroid sulphotase
08/05/2010US20100197647 Compounds that inhibit oestrone sulphatase; compositions thereof; and methods employing the same
08/03/2010CA2523081C Macrolide-conjugates with anti-inflammatory activity
07/2010
07/22/2010US20100184735 Locally active "soft" antiandrogens
07/15/2010US20100179337 Preparation of bile acids and intermediates thereof
07/14/2010CN101775055A Method for synthesizing 4-trifluoromethyl-4-olefine-3-steroidal ketone compound
07/14/2010CN101775054A Synthesis method of 4-hydroxyl-4-alkene-3-ketone steroide compound
07/08/2010WO2010076811A2 Process for the preparation of exemestane
07/08/2010US20100173883 7-hydroxyepiandrosterone having neuroprotective activity
07/07/2010EP2203173A2 Means and methods for counteracting muscle disorders
07/06/2010US7749989 Estrogenic compounds, methods of using and methods of administering the same
07/06/2010US7749987 treating with a mixture comprising nomegestrol acetate and estradiol valerate or estradiol; side effect reduction
06/2010
06/30/2010CN101759740A Method for synthesizing 3-alpha-acetoxy-deoxidized androstane-5-17-ketone
06/22/2010CA2412864C Methods of making, using and pharmaceutical formulations comprising 7.alpha.,11.beta.-dimethyl-17.beta.-hydroxyestra-4,14-dien-3-one and 17 esters thereof
06/22/2010CA2406177C 8.beta.-hydrocarbyl-substituted estratrienes as selectively active estrogens
06/17/2010US20100152148 Novel compounds
06/17/2010US20100152145 Use of 3-alpha-androstanediol, optionally in combination with a pde5 inhibitor, in the treatment of sexual dysfunction
06/16/2010CN1809364B Compositions and methods for increasing telomerase activity
06/10/2010US20100145083 Preparation of bile acids and intermediates thereof
06/10/2010US20100144688 23-Substituted Derivatives of Lupane-type Pentacyclic Triterpenoids
06/09/2010CN101730705A Process for preparing aromatase inhibitors
06/08/2010US7732493 2-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17β-hydroxy steroid dehydrogenase type 1
06/08/2010CA2423960C Separation of cresol from mares' urine
06/03/2010US20100137270 Modulation of prostaglandin/cyclooxygenase metabolic pathways
06/03/2010US20100137269 Novel C-17-Heteroaryl Steroidal Cyp17 Inhibitors/Antiandrogens: Synehesis, In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity
06/03/2010US20100135956 Steroid modulators of progesterone receptor and/or glucocorticoid receptor
06/02/2010CN101717422A Method for producing dehydroepiandros-sterone
05/2010
05/27/2010US20100130463 6-substituted estradiol derivatives and methods of use
05/26/2010EP1562976B1 Synthesis of estetrol via estrone derived steroids
05/25/2010US7723532 Pharmaceutical compositions 3
05/25/2010CA2472379C Process for the preparation of 7.alpha.-methylsteroids
05/25/2010CA2402667C 6-oxygenated steroidal estrogens with aromatic a and b rings
05/19/2010CN101711254A Synthetic bile acid composition, method, and preparation
05/19/2010CN101029069B Kaide glycoside 3-O-beta-Cima glycoside in white fleece-flower root and its use
05/18/2010US7718639 7-hydroxyepiandrosterone having neuroprotective activity
05/12/2010EP2183267A2 Process for preparing 7-alpha-[9-(4,4,5,5,5-pentafluorothiopentyl) nonyl]estra-1,3,5(10)-triene-3,17-beta-diol
05/12/2010EP1644397B1 Specific glucocorticosteroid compound having anti- inflammatory activity
05/12/2010CN1962680B 20-hydroxy-16 alpha- bromo-steroid compound, synthesis method and its uses
05/12/2010CN101085803B Androstane compound and its preparation method and application
05/12/2010CN101085800B Method for preparing 11alpha-hydroxy-4-ene-3,17-androstenedione
04/2010
04/29/2010US20100105934 Fulvestrant intermediate
04/22/2010WO2010043506A1 Method and intermediates for preparing 2-alkoxy and 2-aryloxy estrogen compounds
04/22/2010WO2010043404A1 Processes and intermediates for the production of fulvestrant
04/21/2010EP2176282A2 8-beta-substituted estratrienes as selectively active estrogens
04/20/2010CA2268358C Hormonal composition consisting of an oestrogen compound and of a progestational compound
04/15/2010US20100093680 Use of 3-alpha-androstanediol, optionally in combination with a 5-ht1a agonist, in the treatment of sexual dysfunction
04/15/2010CA2739506A1 Methods for detecting dihydrotestosterone by mass spectrometry
04/14/2010CN101693734A Method for synthesizing 4-oxhydryl-4-olefin-3-ketone steroid
04/13/2010US7696190 16Alpha-methyl or ethyl substituted estrogens
04/13/2010US7696189 ene steroids as anticarcinogenic agent
04/08/2010US20100086915 Detection of esr1 amplification in breast cancer
04/07/2010CN1962678B Adamantane acid andrusol derivatives
04/06/2010US7691835 Therapy for prostate cancer; administering androgen receptor
04/06/2010CA2358505C Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 ... 49